Great Novel Therapeutics Biotech & Medicals (7427.TWO)
TWD 37.0
(0.14%)
TWD 37.0
(0.14%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 644.84 Million TWD | 72.95% |
| 2022 | 372.84 Million TWD | 62.13% |
| 2021 | 229.96 Million TWD | 82.72% |
| 2020 | 125.85 Million TWD | 46.89% |
| 2019 | 85.67 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 700.76 Million TWD | 8.67% |
| 2024 Q2 | 700.76 Million TWD | 0.0% |
| 2023 Q4 | 644.84 Million TWD | 14.9% |
| 2023 FY | 644.84 Million TWD | 72.95% |
| 2023 Q3 | 561.25 Million TWD | -18.2% |
| 2023 Q2 | 686.15 Million TWD | 0.0% |
| 2023 Q1 | 686.15 Million TWD | 84.03% |
| 2022 Q3 | 288.7 Million TWD | 0.0% |
| 2022 FY | 372.84 Million TWD | 62.13% |
| 2022 Q4 | 372.84 Million TWD | 29.14% |
| 2021 FY | 229.96 Million TWD | 82.72% |
| 2020 FY | 125.85 Million TWD | 46.89% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 77.771% |
| Level Biotechnology Inc. | 822.67 Million TWD | 21.615% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 2.99% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -17.513% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 83.44% |
| GlycoNex Incorporation | 1.55 Billion TWD | 58.472% |
| VBI | 452.1 Million TWD | -42.634% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 45.173% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 13.856% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 43.127% |
| Visgeneer Inc. | 397.17 Million TWD | -62.359% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 82.897% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 26.979% |
| Neith Corporation | 192.15 Million TWD | -235.591% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 89.416% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -776.654% |
| Enimmune corporation | 604.82 Million TWD | -6.617% |
| TaiRx, Inc. | 833.74 Million TWD | 22.656% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 79.104% |
| EirGenix Inc. | 11.16 Billion TWD | 94.223% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -12.512% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 62.342% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -335.903% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 38.614% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -114.213% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -46.161% |
| RBC Bioscience Corporation | 753.79 Million TWD | 14.452% |
| BiOptic Inc. | 613.77 Million TWD | -5.063% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -403.603% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 63.745% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 44.396% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 79.24% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -143.655% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -70.432% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 70.132% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 82.071% |
| NaviFUS Corp. | 490.53 Million TWD | -31.458% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 47.39% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 52.702% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -21.866% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 44.476% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 61.066% |
| AP Biosciences Inc | 890.75 Million TWD | 27.607% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 92.438% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -98.937% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 51.648% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 76.214% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 95.803% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -57.181% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -62.491% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 68.937% |
| TCI GENE Inc. | 1.16 Billion TWD | 44.693% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -118.904% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 52.7% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 31.527% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 7.674% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 83.691% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 83.131% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 47.566% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 88.493% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 39.28% |
| Acepodia, Inc. | 6.81 Billion TWD | 90.543% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 83.148% |